Helena Teede is an expert in Endocrinology at Monash Children’s Hospital (Australia). As of October 2026, ScienceLeadR ranks Helena Teede in the top 1% of experts worldwide for Weight Gain, Gonadal Disorders and Adnexal Diseases. Helena Teede has authored 852 publications, the most recent in 2026, and is an investigator in 10 clinical trials, 1 of them ongoing. SLR score: 3,005 (community average: 125). How the SLR is computed.

LeadR Profile

Helena Teede Monash Children’s Hospital Australia
3 005 ScienceLeadR Reputation 3005
Network Map

Endocrinology

Subspecialties: Gynecology - Obstetrics - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1998 - 2026

Source: PubMed

Monash Health

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 852

Citations

Citations: 56 628 1st author: 67 Last author: 272 Unique author: 12


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Driving Implementation-Focused Change for Gender Equity in Medical Leadership: A Consensus-Based Priority-Setting Approach.
PMID 42839302 — physicians, women, gender equity, surveys and questionnaires, mentoring, qualitative research
Med J Aust20260
Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk.
PMID 42669621 — epidemiology, insulin resistance, insulin, internal medicine, ovary, cardiovascular diseases, diagnosis, polycystic ovary syndrome
J Intern Med20260
Strengthening Leadership Pathways for Women Nurses and Midwives: Examining System and Organizational Opportunities in a Mixed-Methods Study.
PMID 42836791 — nurses, change management, nursing care, nursing, gender equity, midwifery, workforce
J Nurs Manag20260
A composite tool for predicting gestational diabetes or hypertensive disorders of pregnancy: development and temporal validation.
PMID 42727299 — diabetes mellitus, diabetes, gestational, pregnancy, probability, eclampsia, history
Comput Biol Med20260
Comparison of live birth rates between calorie-restricted diet and metformin prior to ovulation induction therapy in women with polycystic ovary syndrome and overweight/obesity: a protocol for a multicenter, randomized comparative effectiveness trial.
PMID 42787272 — pregnancy, birth rate, fertility, parturition, pregnancy outcome, ovary, public health, diet, obesity, polycystic ovary syndrome, therapeutics, overweight, live birth, ovulation, caloric restriction, ovulation induction, metformin
Front Public Health20260

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 4
N/A 3
Phase 4 2
Phase 2 1

By status:

Completed 6
Unknown 3
Recruiting 1

By type:

Interventional 10

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 0
multicentric5to9 1
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
CRD vs Met in Patients With Obese PCOS Infertility
NCT06049186 — birth rate, parturition, ovary, infertility, general practice, diet, aged, energy intake, polycystic ovary syndrome, therapeutics, overweight, counseling, carbohydrates, live birth, random allocation, ovulation, caloric restriction, ovulation induction, metformin, women
N/ARecruiting2023

LeadR Networks

Main global connection map